Pfizer Stock News

Pfizer is currently testing a booster dose for 5 to 11-year-olds.

Registered nurse Clarece Glanville gives Robert Dennis-Garcia, 8, his first dose of a COVID-19 vaccine at the Legacy Events Center in Farmington on Jan. 24, 2022. Utah parents are being advised not to overreact to a new study from New York showing that it took just over a month for the COVID-19 vaccine to offer children 5-11 years old virtually no protection from getting the virus while becoming less than 50% effective at keeping them out of the hospital. Mengshin Lin, Deseret News Utah parents are being advised not to overreact to a new study from New York showing that it took just over a month for the COVID-19 vaccine to offer children 5-11 years old virtually no protection from getting the virus while becoming less than 50% effective at keeping them out of the hospital.s “This is one study. Science is very much something where it’s important to look at many pieces of information before we draw conclusions that directly impact what we’re going to do,” state epidemiologist Dr. Leisha Nolen said Tuesday, adding she wants to see what’s happening in other places before accepting the results. “Don’t take this as absolute fact,” she said. “Take this as good information that we really need to look into further.” Nolen said the Utah Department of Health continues to recommend parents get their children vaccinated against COVID-19, even as the state moves toward treating the virus more like the flu or other endemic disease that remains deadly but is not as widespread. “It’s always good to be prepared,” she said, for another wave of COVID-19 that’s “pretty certain” to hit at some point.

Pfizer Canada, a unit of Pfizer (PFE) is recalling all lots of high blood pressure drug Inderal-LA (propranolol hydrochloride) extended release capsules, in 60 mg, 80 mg, 120 mg and 160…

Yet the two-dose shot wasn’t as effective in 5- to 11-year-olds as in adolescents, though the CDC still recommends wide use.

Parents, rejoice! Pfizer’s COVID-19 vaccine gave children 5 and older strong protection against hospitalization and death even during the omicron surge that hit youngsters especially hard, U.S. health officials reported Tuesday. New data from the Centers for Disease Control and Prevention (CDC) come a day after a study of New York children suggested the vaccine… The post Pfizer’s Vaccine Protects Kids From Severe COVID, Including Omicron Variant appeared first on HillReporter.com .

The Real State Of The Union Authored by Simon Black via SovereignMan.com, My fellow Americans. Now that my approval ratings are roughly at the same level as my blood pressure, i.e. barely detectable, and my credibility is nonexistent, I thought I might actually try being honest for a change about the real State of the Union. Just over a year ago when I took oath of office, I talked about “the common objects we love that define us as Americans. . . Opportunity. Security. Liberty. Dignity. Respect. Honor. And yes, the truth.” So let me describe to you the State of our Union in those terms: First, opportunity. Under my leadership, inflation has reached a 40+ year high and shows no signs of abating. I’ve also demonstrated how serious I am about fighting inflation by re-appointing the very same Federal Reserve officials who created the inflation to begin with, to another four-year term. Further, the supply chain crisis we engineered from our cascading failures of labor policy, environmental policy, trade policy, monetary policy, and public health policy, also shows little sign of resolving.

Pfizer Vaccine’s Protection Against COVID , Is Short-Lived in Children Ages 5–11, Study Says. A new study, published in medRxiv, . found that the lower dose of Pfizer''s coronavirus vaccine seems to be less effective than the higher-dose regimens that older children and adults receive. …

A new government report shows Pfizer’s COVID-19 vaccine gave children 5 and older strong protection against hospitalization and death even during the omicron surge

There''s an alarming new study conducted by New York state on the effectiveness of the Pfizer vaccine for children. While the vaccine appears to still be effective at reducing hospitalizations in kids ages 5 to 11, the study said from December to January, the ability to prevent infection dropped sharply from 68% to just 12%.

The two newer studies tracked infections in December and January, as omicron was sweeping across the country.

Does the Pfizer''s Covid-19 vaccine provide less protection to children aged 5 to 11 than to adolescents 12 to 17? Two studies offer divergent answers

According to a published study, Pfizer Inc (NYSE: PFE ) and BioNTech SE''s (NASDAQ: BNTX ) two-dose COVID-19 vaccine provided very little protection for children aged 5 to 11 years during the wave of omicron infection in New York. The vaccine''s efficacy against infection among those children declined to 12% at the end of January from 68% in mid-December compared to kids who did not get … Full story available on Benzinga.com

Pfizer Inc (NYSE: PFE ) announced data from the CLOVER Phase 3 trial evaluating Clostridioides difficile vaccine candidate to prevent C. difficile infection (CDI). Initial analyses of two secondary endpoints indicated a highly favorable benefit in reducing CDI severity and 100% vaccine efficacy in preventing medically attended CDI. However, the trial did not … Full story available on Benzinga.com

TWO DOSES of the Pfizer, Inc. and BioNTech SE coronavirus disease 2019 (COVID-19) vaccine was protective against severe disease in children aged 5 to 11 during the recent Omicron variant surge, but quickly lost most of its ability to prevent infection in the age group, according to a study by New York State researchers.

New York State Health officials found that Pfizer''s mRNA vaccine was not as effective within this age group.